Chisholm Timothy S, Hunter Christopher A
Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
Chem Rev. 2025 Jun 11;125(11):5282-5348. doi: 10.1021/acs.chemrev.4c00838. Epub 2025 May 6.
Amyloid fibrils are characteristic features of many neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The use of small molecule ligands that bind to amyloid fibrils underpins both fundamental research aiming to better understand the pathology of neurodegenerative disease, and clinical research aiming to develop diagnostic tools for these diseases. To date, a large number of amyloid-binding ligands have been reported in the literature, predominantly targeting protein fibrils composed of amyloid-β (Aβ), tau, and α-synuclein (αSyn) fibrils. Fibrils formed by a particular protein can adopt a range of possible morphologies, but protein fibrils formed possess disease-specific morphologies, highlighting the need for morphology-specific amyloid-binding ligands. This review details the morphologies of Aβ, tau, and αSyn fibril polymorphs that have been reported as a result of structural work and describes a database of amyloid-binding ligands containing 4,288 binding measurements for 2,404 unique compounds targeting Aβ, tau, or αSyn fibrils.
淀粉样纤维是许多神经退行性疾病的特征性表现,包括阿尔茨海默病和帕金森病。使用与淀粉样纤维结合的小分子配体,既为旨在更好地理解神经退行性疾病病理学的基础研究提供了支持,也为旨在开发这些疾病诊断工具的临床研究提供了支持。迄今为止,文献中已报道了大量的淀粉样纤维结合配体,主要针对由淀粉样β蛋白(Aβ)、tau蛋白和α-突触核蛋白(αSyn)纤维组成的蛋白质纤维。由特定蛋白质形成的纤维可以呈现一系列可能的形态,但形成的蛋白质纤维具有疾病特异性形态,这凸显了对形态特异性淀粉样纤维结合配体的需求。本综述详细介绍了由于结构研究而报道的Aβ、tau和αSyn纤维多晶型的形态,并描述了一个淀粉样纤维结合配体数据库,该数据库包含针对Aβ、tau或αSyn纤维的2404种独特化合物的4288次结合测量。